Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three sessions, experts believe the panic is unfounded, maintaining confidence in the sectors’ long-term outlook. Trump’s recent 25% tariffs on auto exports to the US, along with additional duties, have further affected market sentiment.
BofA initiates coverage on Polycab, KEI with buy ratings; sees up to 22% upside
BofA expects India’s wires and cables industry to grow at a 14% compound annual rate between FY26 and FY29, supported by spending on infrastructure, renewable